	Pharmacologically targeting protein lactylation to overcome cancer drug resistance. Eur J Med Chem Wang Y, Chen J, Wang Y, Zhao J, Zhang J, Wang H. PMID: 40592066 [PubMed - as supplied by publisher]
	Pan-cancer analysis of the impact of fatty acids: a two-sample and multivariable Mendelian randomization study. Discov Oncol Kuang X, Wu B, Hu D, Matsika J, Cheng C, Xiao J, Cai Z, Li M, Chen J, Zhou W, Liu B. PMID: 40591044 [PubMed]
	Harnessing artificial intelligence for detection of pancreatic cancer: a machine learning approach. Clin Exp Med Khorsand B, Hesami Z, Alipour S, Farmani M, Houri H. PMID: 40591038 [PubMed - indexed for MEDLINE]
	Risk Factors and Vascular Features Associated With Local Recurrence in Pancreatic Cancer Post-Pancreaticoduodenectomy: A Retrospective Cohort Study. Cancer Rep (Hoboken) Liao TK, Chao YJ, Lu WH, Su PJ, Wang CJ, Shan YS. PMID: 40590307 [PubMed - indexed for MEDLINE]
	Perioperative Clinical Usage of Phellinus Linteus as a Nutraceutical for Non-FOLFIRINOX-Based Postoperative Adjuvant Chemotherapy for Resected Pancreatic Cancer: A Retrospective Cohort Study. Integr Cancer Ther Kim J, Hong SS, Kim SH, Hwang HK, Kang CM. PMID: 40590265 [PubMed - indexed for MEDLINE]
	Case Report: Diagnosing and treating gallbladder neuroendocrine neoplasms through comparative analysis: a case series and literature review. Front Oncol Zhang J, Li J, Dong Y, Lu B. PMID: 40589647 [PubMed]
	Model Construction for Predicting Preoperative Microvascular Invasion of Hepatocellular Carcinoma by Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging Combined with Serology. Med Sci Monit Sheng S, Fu X, Li M, Ye W, Chen X, Chen C. PMID: 40589065 [PubMed - indexed for MEDLINE]
	Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort. J Immunother Cancer Patel SP, Fisher J, Chae YK, Soto LS, Kasi A, Konda B, Walshauser M, Parra E, Zhang J, Duault C, Gonzalez-Kozlova E, Manyam G, Zhang J, Chen H, Duose DY, Laberiano Fernandez C, Luthra R, Al-Atrash G, Kim-Schulze S, Maecker HT, Wistuba II, Gnjatic S, Lee JJ, Zhang J, Magner CM, Chen HX, Sharon E, Othus M, Ryan CW, Blanke C, Haymaker CL, Kurzrock R. PMID: 40588371 [PubMed - indexed for MEDLINE]
	IND-Enabling Studies for a TCR-T targeting a pancreatic cancer G12V KRAS mutation. Clin Cancer Res Wang S, Yu G, Dai Y, Gan C, Qiu S, Zhang X, Jiang X, Wei R, Yang J, Wu D, Chen L, Huang L, Li M, Xiao Y, Shen R, Chen Y, Zhu D, Yao A, Ouyang Y, Sun Z, Wang X, Hu HM. PMID: 40586688 [PubMed - as supplied by publisher]
	Advances in neoadjuvant therapy for pancreatic cancer: Current trends and future directions. World J Clin Oncol Wu ST, Zhu L, Feng XL, Yang L, Chen GW, Jiang Y, Huang TF, Wang HY, Li F. PMID: 40585822 [PubMed]
	Nanomaterial-assisted pancreatic cancer theranostics. Regen Biomater Liu Y, Xu H, Bai S, Chen T, Ma X, Lin J, Sun L, Gao C, Wu A, Li Q. PMID: 40585530 [PubMed]
	Genetically predicted serum urate and cancer risk: a Mendelian randomization study. Scand J Rheumatol Fatima T, Dehlin M, Burgess S, Mason AM, Nilsson PM, Melander O, Jacobsson L, Kapetanovic MC. PMID: 40583621 [PubMed - as supplied by publisher]
	ADJUPANC protocol: a phase III study of adjuvant chemotherapy versus chemoradiotherapy for pancreatic cancer. Future Oncol Zhu X, Liu W, Jiang L, Cao Y, Ye Y, Yu C, Yin X, Zhang H. PMID: 40583350 [PubMed - as supplied by publisher]
	Impact of Preoperative Chemotherapy on Physical Function in Patients With Borderline Resectable Pancreatic Cancer: A Retrospective Study. Integr Cancer Ther Kouda K, Asaeda M, Nakashima Y, Araki T, Kawasaki S, Ishida A, Nagao T, Maeda N, Urabe Y, Mikami Y. PMID: 40583313 [PubMed - indexed for MEDLINE]
	Pancreatic organoids as cancer avatars for true personalized medicine. Adv Drug Deliv Rev Gout J, Ekizce M, Roger E, Kleger A. PMID: 40582468 [PubMed - as supplied by publisher]
	Efficacy of Neoadjuvant Therapy in Gallbladder Cancer - a meta-analysis utilising reconstructed time-to-event data. J Gastrointest Surg Loke S, Low CE, Ong BDC, Xie K, Kow AWC, Law JH. PMID: 40581320 [PubMed - as supplied by publisher]
	PARPs and ADP-ribosyl hydrolases in cancer therapy: From drug targets to biomarkers. DNA Repair (Amst) Groslambert J, Schützenhofer K, Palazzo L, Ahel I. PMID: 40580812 [PubMed - as supplied by publisher]
	Decoding the pancreatic cancer microenvironment: The multifaceted regulation of microRNAs. Clin Transl Med Ji J, Jin D, Zhao J, Xie X, Jiao Y, He X, Huang Y, Zhou L, Xiao M, Cao X. PMID: 40579785 [PubMed - indexed for MEDLINE]
	Concordance of laboratory assays for claudin 18.2 in gastric cancer tissue samples: independent proficiency testing and a descriptive non-interventional study. Virchows Arch Röcken C, Höhn AK, Neumann J, Schildhaus HU, Singer S, Clauditz TS, Quaas A, Jöhrens K. PMID: 40579565 [PubMed - as supplied by publisher]
	Predictors of recurrent venous thromboembolism and bleeding in patients with cancer: a meta-analysis. Eur Heart J Khan F, Tritschler T, Marx CE, Lanting V, Rochwerg B, Tran A, Fernando SM, Lorenzetti DL, Wunsch H, Holodinsky J, Fiest K, Stelfox HT, Delluc A, Fergusson DA, Le Gal G, Wells PS, Wang TF, Sanfilippo K, van Es N, Schrag D, Connors JM, Carrier M. PMID: 40579365 [PubMed - as supplied by publisher]

Articles 1 - 20 / 56050

Page 1 of 2803



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy